Peter Michael Moyle
Impact in
- Microbiology top 2%
- Antimicrobial Peptides and Activities
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
- Microbiology 11
- Antimicrobial Peptides and Activities 7
- Immunology 16
- Immunotherapy and Immune Responses 9
- Co-authors
- István Tóth (42 shared papers)Seyed Ebrahim Alavi (4 shared papers)Michael F. Good (17 shared papers)Peter John Cabot (3 shared papers)Michael R. Batzloff (9 shared papers)Colleen Olive (12 shared papers)Pavla Simerská (5 shared papers)Anjuman Ara Begum (6 shared papers)
- Journals
- Nanomedicine (6 papers)Journal of Medicinal Chemistry (4 papers)Bioconjugate Chemistry (4 papers)Bioorganic & Medicinal Chemistry (4 papers)Current Drug Delivery (3 papers)
- Partner nations
- AustraliaUnited StatesSaudi Arabia
In The Last Decade
Peter Michael Moyle
65 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 122
- Microbiology 257
- Immunology 710
- Pharmaceutical Science 132
- Infectious Diseases 358
- Molecular Biology 1.1k
Countries citing papers authored by Peter Michael Moyle
This map shows the geographic impact of Peter Michael Moyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Michael Moyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Michael Moyle more than expected).
Fields of papers citing papers by Peter Michael Moyle
This network shows the impact of papers produced by Peter Michael Moyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Michael Moyle. The network helps show where Peter Michael Moyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Michael Moyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 390 | |
| 2 | 2008 | 133 | |
| 3 | 2017 | 88 | |
| 4 | 2019 | 82 | |
| 5 | 2019 | 75 | |
| 6 | 2018 | 69 | |
| 7 | 2019 | 65 | |
| 8 | 2023 | 62 | |
| 9 | 2021 | 61 | |
| 10 | 2007 | 59 | |
| 11 | 2010 | 57 | |
| 12 | 2016 | 54 | |
| 13 | 2004 | 53 | |
| 14 | 2017 | 50 | |
| 15 | 2014 | 48 | |
| 16 | 2020 | 46 | |
| 17 | 2009 | 46 | |
| 18 | 2013 | 46 | |
| 19 | 2007 | 43 | |
| 20 | 2015 | 41 |
About Peter Michael Moyle
Peter Michael Moyle is a scholar working on Microbiology, Immunology, Molecular Biology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 67 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Streptococcal Infections and Treatments (14 papers), Biochemical and Structural Characterization (10 papers), Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), vaccines and immunoinformatics approaches (8 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Antimicrobial Peptides and Activities (7 papers). The work is most often cited by research in Microbiology (257 citations), Immunology (710 citations), Pharmaceutical Science (132 citations), Infectious Diseases (358 citations) and Molecular Biology (1.1k citations). Peter Michael Moyle has collaborated with scholars based in Australia, United States and Saudi Arabia. Frequent co-authors include István Tóth, Seyed Ebrahim Alavi, Michael F. Good, Peter John Cabot, Michael R. Batzloff, Colleen Olive, Pavla Simerská, Anjuman Ara Begum, Yu Wan and Zyta Maria Ziora. Their work appears in journals such as Nanomedicine, Journal of Medicinal Chemistry, Bioconjugate Chemistry, Bioorganic & Medicinal Chemistry and Current Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.